Literature DB >> 21734116

Ivermectin mass drug administration to humans disrupts malaria parasite transmission in Senegalese villages.

Kevin C Kobylinski1, Massamba Sylla, Phillip L Chapman, Moussa D Sarr, Brian D Foy.   

Abstract

Ivermectin mass drug administration (MDA) to humans is used to control onchocerciasis and lymphatic filariasis. Recent field studies have shown an added killing effect of ivermectin MDA against malaria vectors. We report that ivermectin MDA reduced the proportion of Plasmodium falciparum infectious Anopheles gambiae sensu stricto (s.s.) in treated villages in southeastern Senegal. Ivermectin MDA is a different delivery method and has a different mode of action from current malaria control agents. It could be a powerful and synergistic new tool to reduce malaria transmission in regions with epidemic or seasonal malaria transmission, and the prevalence and intensity of neglected tropical diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21734116      PMCID: PMC3122335          DOI: 10.4269/ajtmh.2011.11-0160

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  21 in total

1.  Drug-resistant Drosophila indicate glutamate-gated chloride channels are targets for the antiparasitics nodulisporic acid and ivermectin.

Authors:  N S Kane; B Hirschberg; S Qian; D Hunt; B Thomas; R Brochu; S W Ludmerer; Y Zheng; M Smith; J P Arena; C J Cohen; D Schmatz; J Warmke; D F Cully
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Effect of ivermectin on Anopheles gambiae mosquitoes fed on humans: the potential of oral insecticides in malaria control.

Authors:  Carlos Chaccour; Jo Lines; Christopher J M Whitty
Journal:  J Infect Dis       Date:  2010-07-01       Impact factor: 5.226

3.  Frequent blood-feeding and restrictive sugar-feeding behavior enhance the malaria vector potential of Anopheles gambiae s.l. and An. funestus (Diptera:Culicidae) in western Kenya.

Authors:  J C Beier
Journal:  J Med Entomol       Date:  1996-07       Impact factor: 2.278

4.  Malaria vector control and personal protection.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2006

5.  Ivermectin, a new broad-spectrum antiparasitic agent.

Authors:  J C Chabala; H Mrozik; R L Tolman; P Eskola; A Lusi; L H Peterson; M F Woods; M H Fisher; W C Campbell; J R Egerton; D A Ostlind
Journal:  J Med Chem       Date:  1980-10       Impact factor: 7.446

6.  A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children.

Authors:  H Marti; H J Haji; L Savioli; H M Chwaya; A F Mgeni; J S Ameir; C Hatz
Journal:  Am J Trop Med Hyg       Date:  1996-11       Impact factor: 2.345

Review 7.  A research agenda for malaria eradication: vector control.

Authors: 
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

8.  Mass drug administration of ivermectin in south-eastern Senegal reduces the survivorship of wild-caught, blood fed malaria vectors.

Authors:  Massamba Sylla; Kevin C Kobylinski; Meg Gray; Phillip L Chapman; Moussa D Sarr; Jason L Rasgon; Brian D Foy
Journal:  Malar J       Date:  2010-12-20       Impact factor: 2.979

9.  PCR-based detection of Plasmodium in Anopheles mosquitoes: a comparison of a new high-throughput assay with existing methods.

Authors:  Chris Bass; Dimitra Nikou; Andrew M Blagborough; John Vontas; Robert E Sinden; Martin S Williamson; Linda M Field
Journal:  Malar J       Date:  2008-09-15       Impact factor: 2.979

10.  The global programme to eliminate lymphatic filariasis: health impact after 8 years.

Authors:  Eric A Ottesen; Pamela J Hooper; Mark Bradley; Gautam Biswas
Journal:  PLoS Negl Trop Dis       Date:  2008-10-08
View more
  61 in total

1.  Facts and ideas from anywhere.

Authors:  William C Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-10

2.  Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum In Vitro.

Authors:  Lais Pessanha de Carvalho; Thaisa Lucas Sandri; Edésio José Tenório de Melo; Rolf Fendel; Peter G Kremsner; Benjamin Mordmüller; Jana Held
Journal:  Antimicrob Agents Chemother       Date:  2019-07-25       Impact factor: 5.191

3.  Novel control strategies for mosquito-borne diseases.

Authors:  Robert T Jones; Thomas H Ant; Mary M Cameron; James G Logan
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-12-28       Impact factor: 6.237

4.  Endectocides for malaria control.

Authors:  Brian D Foy; Kevin C Kobylinski; Ines Marques da Silva; Jason L Rasgon; Massamba Sylla
Journal:  Trends Parasitol       Date:  2011-07-03

5.  Mosquitocidal properties of IgG targeting the glutamate-gated chloride channel in three mosquito disease vectors (Diptera: Culicidae).

Authors:  Jacob I Meyers; Meg Gray; Brian D Foy
Journal:  J Exp Biol       Date:  2015-05-15       Impact factor: 3.312

6.  Characterization of the target of ivermectin, the glutamate-gated chloride channel, from Anopheles gambiae.

Authors:  Jacob I Meyers; Meg Gray; Wojtek Kuklinski; Lucas B Johnson; Christopher D Snow; William C Black; Kathryn M Partin; Brian D Foy
Journal:  J Exp Biol       Date:  2015-05-15       Impact factor: 3.312

7.  The effect of ivermectin in seven strains of Aedes aegypti (Diptera: Culicidae) including a genetically diverse laboratory strain and three permethrin resistant strains.

Authors:  K M Deus; K Saavedra-Rodriguez; M P Butters; W C Black; B D Foy
Journal:  J Med Entomol       Date:  2012-03       Impact factor: 2.278

8.  Gates Grand Challenges Explorations award: Endectocides for Controlling Transmission of Mosquito-borne Diseases.

Authors:  Massamba Sylla; Kevin C Kobylinski; Brian D Foy
Journal:  Malariaworld J       Date:  2013-03

9.  Rationale for the coadministration of albendazole and ivermectin to humans for malaria parasite transmission control.

Authors:  Kevin C Kobylinski; Haoues Alout; Brian D Foy; Archie Clements; Poom Adisakwattana; Brett E Swierczewski; Jason H Richardson
Journal:  Am J Trop Med Hyg       Date:  2014-07-28       Impact factor: 2.345

10.  Ivermectin treatment in humans for reducing malaria transmission.

Authors:  Dziedzom K de Souza; Rebecca Thomas; John Bradley; Clemence Leyrat; Daniel A Boakye; Joseph Okebe
Journal:  Cochrane Database Syst Rev       Date:  2021-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.